Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121

被引:4
|
作者
Lee, Wen Shi [1 ]
Reynaldi, Arnold [2 ]
Amarasena, Thakshila [1 ]
Davenport, Miles P. [2 ]
Parsons, Matthew S. [1 ,3 ,4 ]
Kent, Stephen J. [1 ,5 ]
机构
[1] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[2] Univ New South Wales, Kirby Inst, Kensington, NSW, Australia
[3] Emory Univ, Sch Med, Dept Pathol, Lab Med, Atlanta, GA 30322 USA
[4] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA
[5] Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr & Dept Infect Dis, Melbourne, Vic, Australia
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
HIV; broadly neutralizing antibodies (bNAb); PGT121; anti-drug antibodies (ADA); pigtailed macaque; MONOCLONAL-ANTIBODIES; NONHUMAN-PRIMATES; PROTECTION; VIREMIA; DELIVERY;
D O I
10.3389/fimmu.2021.749891
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic administration of the anti-HIV bNAb PGT121 (either WT or LALA version) controlled viraemia in pigtailed macaques with ongoing SHIV infection. We now report on 23 macaques that had multiple treatments with PGT121. We found that an increasing number of intravenous doses of PGT121 or human IgG1 isotype control antibodies (2-4 doses) results in anti-PGT121 ADA induction and low plasma concentrations of PGT121. ADA was associated with poor or absent suppression of SHIV viremia. Notably, ADA within macaque plasma recognised another human bNAb 10E8 but did not bind to the variable domains of PGT121, suggesting that ADA were primarily directed against the constant regions of the human antibodies. These findings have implications for the development of preclinical studies examining multiple infusions of human bNAbs.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
    Seaman, Michael S.
    Bilska, Miroslawa
    Ghantous, Fadi
    Eaton, Amanda
    LaBranche, Celia C.
    Greene, Kelli
    Gao, Hongmei
    Weiner, Joshua A.
    Ackerman, Margaret E.
    Garber, David A.
    Rosenberg, Yvonne J.
    Sarzotti-Kelsoe, Marcella
    Montefiori, David C.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2020, 479
  • [42] Application of an ELISA based competitive binding assay to measure concentration of anti-TNF biologics and neutralising anti-drug antibodies in the clinical laboratory
    Keating, P.
    Hock, B.
    Barclay, M.
    Stamp, L.
    Spellerberg, M.
    O'Donnell, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1033 - 1033
  • [43] NICOTIANA-PRODUCED BROADLY NEUTRALIZING ANTI-HIV MONOCLONAL ANTIBODIES AS A MICROBICIDE STRATEGY IN CYNOMOLGUS MACAQUES
    Zhao, Chunxia
    Connor-Stroud, Fawn
    Sharma, Prachi
    Oviedo-Moreno, Patricia
    Whaley, Kevin
    Bohorov, Ognian
    Moench, Tom
    Anderson, Deborah J.
    Villinger, Francois
    JOURNAL OF MEDICAL PRIMATOLOGY, 2014, 43 (05) : 394 - 394
  • [44] Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies
    Stubenrauch, Kay
    Mackeben, Klaus
    Vogel, Rudolf
    Heinrich, Julia
    ANALYTICAL BIOCHEMISTRY, 2012, 430 (02) : 193 - 199
  • [45] Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model
    Bhol, Kailash
    Erlich, Emma
    Lemos, Brenda
    Tracey, Daniel
    Hartman, Deborah
    Fox, Barbara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S545 - S546
  • [46] The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
    Vaisman-Mentesh, Anna
    Gutierrez-Gonzalez, Matias
    DeKosky, Brandon J.
    Wine, Yariv
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [47] A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
    Davis-Gardner, Meredith E.
    Weber, Jesse A.
    Xie, Jun
    Pekrun, Katja
    Alexander, Eric A.
    Weisgrau, Kim L.
    Furlott, Jessica R.
    Rakasz, Eva G.
    Kay, Mark A.
    Gao, Guangping
    Farzan, Michael
    Gardner, Matthew R.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
    Shingai, Masashi
    Donau, Olivia K.
    Plishka, Ronald J.
    Buckler-White, Alicia
    Mascola, John R.
    Nabel, Gary J.
    Nason, Martha C.
    Montefiori, David
    Moldt, Brian
    Poignard, Pascal
    Diskin, Ron
    Bjorkman, Pamela J.
    Eckhaus, Michael A.
    Klein, Florian
    Mouquet, Hugo
    Lorenzi, Julio Cesar Cetrulo
    Gazumyan, Anna
    Burton, Dennis R.
    Nussenzweig, Michel C.
    Martin, Malcolm A.
    Nishimura, Yoshiaki
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (10): : 2061 - 2074
  • [49] EBF recommendation for stability testing of anti-drug antibodies; lessons learned from anti-vaccine antibody stability studies
    Pihl, Susanne
    Michaut, Lydia
    Hendriks, Jenny
    Loebbert, Ralf
    Ryding, Janka
    Nemansky, Martin
    Vermet, Laurent
    Companjen, Arjen
    BIOANALYSIS, 2014, 6 (10) : 1409 - 1413
  • [50] A bridging assay for detection and characterization of anti-drug antibodies to dostarlimab, a new anti-PD-1 therapeutic monoclonal antibody
    Marilyn Patterson
    Lee Anne Beausang
    Bonita Rup
    Ronald R. Bowsher
    Kim Krug
    Murad Melhem
    Sharon Lu
    AAPS Open, 7 (1)